_ OUR NEWS

OCULUS BIOMED NEWS

August 19, 2025
Published by admin on August 19, 2025
Categories
Data Indicate OBM’s OBM1701 Diffuses into the Retina and RPE and Effectively Alleviates Choroidal Neovascularisation in wet-AMD Animal Model after Topically Applied Has Been Published on An Association for Research in Vision and Ophthalmology (ARVO) Official Journal – 19th August 2025
Oculus Biomed Limited (“OBM”) is pleased to announce that the research data which covers OBM’s OBM1701, its leading drug candidate for the treatment of wet-AMD, has […]
Do you like it?0
Read more
July 30, 2025
Published by admin on July 30, 2025
Categories
OBM Was Invited by Our Legal Advisor Firm Steinepreis Paganin to Attend IPO Network’s Exclusive Event in Melbourne
30th July 2025
Oculus Biomed Limited (“OBM”) is invited by its legal advisor, Steinepreis Paganin (“SP”), to attend a function held by the IPO Network, on the evening of […]
Do you like it?2
Read more
July 27, 2025
Published by admin on July 27, 2025
Categories
OBM Attends BioAsia-Taiwan Conference and ACRO Biomedical Announces to Outlicense the Market Rights in 10 ASEAN Countries of its Biocompatible Artificial Cornea, ABCcolla Collagen Ophthalmic Matrix, to Vietnam’s CT Group
23th ~ 27 July 2025
ACRO Biomedical’s Chairman & CEO Dr Hsieh (left) & OBM’s CSO Dr Jiang (right) met for business discussion at 2025 BioAsia Taiwan Conference. ACRO Biomedical’s Chairman […]
Do you like it?2
Read more
July 14, 2025
Published by admin on July 14, 2025
Categories
Professor Mark Daniell Joined to OBM Scientific Board
14th July 2025
We highly welcome Professor Mark Daniell to join the OBM Scientific Board. He brings significant experience of medical research and clinical surgery to the company.   […]
Do you like it?3
Read more
March 14, 2025
Published by admin on March 14, 2025
Categories
Our Partner ACRO Biomedical Co., Ltd. Receives Approval for Its Biocompatible Cornea from Taiwan FDA, the Department of Health and Welfare
14th March 2025
  Our strategic partner and major shareholder, ACRO Biomedical Co., Ltd., a public listed company on Taiwan Stock Exchange and one of the Taiwan’s leading biomedical […]
Do you like it?2
Read more
November 27, 2023
Published by admin on November 27, 2023
Categories
Mr Roger McPherson appointed CFO / Company Secretary
27 Nov 2023
OBM is delighted to welcome Roger to the executive team. He brings significant technical skill and industry experience to the company. Roger has more than 30 […]
Do you like it?15
Read more
12345
Next page